Philip F. Watson

1.6k total citations
34 papers, 1.3k citations indexed

About

Philip F. Watson is a scholar working on Immunology, Cell Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Philip F. Watson has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 11 papers in Cell Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Philip F. Watson's work include melanin and skin pigmentation (11 papers), T-cell and B-cell Immunology (10 papers) and Thyroid Disorders and Treatments (8 papers). Philip F. Watson is often cited by papers focused on melanin and skin pigmentation (11 papers), T-cell and B-cell Immunology (10 papers) and Thyroid Disorders and Treatments (8 papers). Philip F. Watson collaborates with scholars based in United Kingdom, United States and Poland. Philip F. Watson's co-authors include Anthony P. Weetman, E. Helen Kemp, David J. Gawkrodger, Elizabeth A. Waterman, Timothy S. Johnson, Russell Metcalfe, Bart Wagner, Graham L. Thomas, A. Meguid El Nahas and Nikos G. Gavalas and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Philip F. Watson

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip F. Watson United Kingdom	20	394	335	317	299	171	34	1.3k
Klementina Fon Tacer United States	18	245 0.6×	149 0.4×	1.4k 4.4×	154 0.5×	45 0.3×	34	2.1k
Susan C. Kiley United States	23	159 0.4×	240 0.7×	1.2k 3.8×	100 0.3×	123 0.7×	36	1.9k
Jan Hilpert Germany	14	85 0.2×	212 0.6×	672 2.1×	103 0.3×	62 0.4×	25	1.4k
Zhi‐Ming Ding United States	19	335 0.9×	198 0.6×	700 2.2×	703 2.4×	85 0.5×	47	1.9k
Venkanna Pasham Germany	15	101 0.3×	73 0.2×	603 1.9×	183 0.6×	93 0.5×	25	1.1k
Gisèle Cherqui France	21	169 0.4×	168 0.5×	1.2k 3.8×	232 0.8×	53 0.3×	66	1.8k
W S Lee United States	13	172 0.4×	65 0.2×	945 3.0×	471 1.6×	196 1.1×	15	1.9k
Régis Bobe France	29	179 0.5×	374 1.1×	1.0k 3.3×	59 0.2×	62 0.4×	60	2.1k
Fukushi Kambe Japan	26	207 0.5×	143 0.4×	1.1k 3.4×	525 1.8×	64 0.4×	75	2.0k
Celia M. Pombo Spain	20	127 0.3×	345 1.0×	980 3.1×	160 0.5×	51 0.3×	27	1.6k

Countries citing papers authored by Philip F. Watson

Since Specialization

Citations

This map shows the geographic impact of Philip F. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip F. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip F. Watson more than expected).

Fields of papers citing papers by Philip F. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip F. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip F. Watson. The network helps show where Philip F. Watson may publish in the future.

Co-authorship network of co-authors of Philip F. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Philip F. Watson. A scholar is included among the top collaborators of Philip F. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip F. Watson. Philip F. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Huang, Linghong, Hélène Bon, Mabrouka Maamra, et al.. (2024). The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease. PLoS ONE. 19(5). e0298864–e0298864. 3 indexed citations

2.

Kemp, E. Helen, Harpreet Sandhu, Philip F. Watson, & Anthony P. Weetman. (2013). Low Frequency of Pendrin Autoantibodies Detected Using a Radioligand Binding Assay in Patients With Autoimmune Thyroid Disease. The Journal of Clinical Endocrinology & Metabolism. 98(2). E309–E313. 4 indexed citations

3.

Kemp, E. Helen, et al.. (2010). Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Experimental Dermatology. 20(1). 35–40. 57 indexed citations

4.

Waterman, Elizabeth A., David J. Gawkrodger, Philip F. Watson, Anthony P. Weetman, & E. Helen Kemp. (2009). Autoantigens in Vitiligo Identified by the Serological Selection of a Phage-Displayed Melanocyte cDNA Expression Library. Journal of Investigative Dermatology. 130(1). 230–240. 21 indexed citations

5.

Gavalas, Nikos G., Raju V.S.R.K. Gottumukkala, David J. Gawkrodger, et al.. (2009). Mapping of melanin‐concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Experimental Dermatology. 18(5). 454–463. 12 indexed citations

6.

Gavalas, Nikos G., E. Helen Kemp, Kai Krohn, et al.. (2007). The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1. The Journal of Clinical Endocrinology & Metabolism. 92(6). 2107–2114. 58 indexed citations

7.

Gavalas, Nikos G., Samia Akhtar, David J. Gawkrodger, et al.. (2006). Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochemical and Biophysical Research Communications. 345(4). 1586–1591. 59 indexed citations

8.

Góra, Monika, Andrzej Gardas, Philip F. Watson, et al.. (2004). Key residues contributing to dominant conformational autoantigenic epitopes on thyroid peroxidase identified by mutagenesis. Biochemical and Biophysical Research Communications. 320(3). 795–801. 17 indexed citations

9.

Gottumukkala, Raju V.S.R.K., et al.. (2003). Autoantibodies in Vitiligo Patients Recognize Multiple Domains of the Melanin-Concentrating Hormone Receptor. Journal of Investigative Dermatology. 121(4). 765–770. 15 indexed citations

10.

Kemp, E. Helen, Russell Metcalfe, Karen Smith, et al.. (2003). Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clinical Endocrinology. 59(2). 207–213. 80 indexed citations

11.

Kemp, E. Helen, Elizabeth A. Waterman, Brian E. Hawes, et al.. (2002). The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. Journal of Clinical Investigation. 109(7). 923–930. 87 indexed citations

12.

Kemp, E. Helen, Elizabeth A. Waterman, Brian E. Hawes, et al.. (2002). The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. Journal of Clinical Investigation. 109(7). 923–930. 96 indexed citations

13.

Kemp, E. Helen, et al.. (2002). Immunoscreening of phage-displayed cDNA-encoded polypeptides identifies B cell targets in autoimmune disease. Biochemical and Biophysical Research Communications. 298(1). 169–177. 18 indexed citations

14.

Yang, Bin, Timothy S. Johnson, Graham L. Thomas, et al.. (2002). A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis. Kidney International. 62(4). 1301–1313. 5 indexed citations

15.

Yang, Bin, Timothy S. Johnson, Graham L. Thomas, et al.. (2002). A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis. Kidney International. 62(4). 1301–1313. 95 indexed citations

16.

Taylor, Julie P., Russell Metcalfe, Philip F. Watson, Anthony P. Weetman, & Richard C. Trembath. (2002). Mutations of thePDSGene, Encoding Pendrin, Are Associated with Protein Mislocalization and Loss of Iodide Efflux: Implications for Thyroid Dysfunction in Pendred Syndrome. The Journal of Clinical Endocrinology & Metabolism. 87(4). 1778–1784. 121 indexed citations

17.

Yang, Bin, Timothy S. Johnson, Graham L. Thomas, et al.. (2001). Apoptosis and Caspase-3 in Experimental Anti-Glomerular Basement Membrane Nephritis. Journal of the American Society of Nephrology. 12(3). 485–495. 41 indexed citations

18.

Yang, Bin, A. Meguid El Nahas, Graham L. Thomas, et al.. (2001). Caspase-3 and apoptosis in experimental chronic renal scarring. Kidney International. 60(5). 1765–1776. 62 indexed citations

19.

Kemp, E. Helen, Elizabeth A. Waterman, Philip F. Watson, Anthony P. Weetman, & David J. Gawkrodger. (1999). Identification of Epitopes on Tyrosinase which are Recognized by Autoantibodies from Patients with Vitiligo. Journal of Investigative Dermatology. 113(2). 267–271. 23 indexed citations

20.

McIntosh, Richard S., Philip F. Watson, & Anthony P. Weetman. (1997). Analysis of the T Cell Receptor Vα Repertoire in Hashimoto’s Thyroiditis: Evidence for the Restricted Accumulation of CD8⁺T Cells in the Absence of CD4⁺T Cell Restriction¹. The Journal of Clinical Endocrinology & Metabolism. 82(4). 1140–1146. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact